Valuations of Asian stocks slip to a 16-month low

(Reuters) – Valuations of Asian equities hit a 16-month low at the end of September, as concerns over an economic slowdown in China and growing expectations of monetary policy tightening by major central banks dragged down equity markets.FILE PHOTO: A pedestrian holding an umbrella looks at an electronic board the

Grab trims full-year forecasts, says $40 billion SPAC merger on track

FILE PHOTO: A Grab logo is pictured at the Money 20/20 Asia Fintech Trade Show in Singapore March 21, 2019. REUTERS/Anshuman DagaSINGAPORE (Reuters) – Grab, Southeast Asia’s biggest ride hailing-to-food delivery group, lowered its full-year forecasts on Tuesday, citing renewed uncertainty over pandemic-related movement restrictions despite encouraging vaccination rates in

Lowe's forecasts higher sales as big-ticket purchases offset DIY slowdown

FILE PHOTO: Shoppers load a box of merchandise into a truck after visiting a Lowe’s hardware store in Philadelphia, Pennsylvania, U.S. November 4, 2020. REUTERS/Mark Makela (Reuters) -Lowe’s Cos Inc forecast full-year sales above estimates on Wednesday, as higher spending on big-ticket items offset some of the slowdown in demand

Aviva to return $5.5 billion to investors, Cevian demands more

LONDON (Reuters) -British insurer Aviva pledged on Thursday to return at least 4 billion pounds ($5.5 billion) to shareholders, sending its shares surging, but activist investor Cevian Capital demanded more.FILE PHOTO: An Aviva logo sits on the window of the company head office in the city of London, Britain March

Clorox forecasts annual sales drop as pandemic boom fades, shares fall

FILE PHOTO: Bottles of Clorox bleach are displayed for sale on the shelves of a Wal-Mart store in Rogers, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi (Reuters) -Clorox Co on Tuesday signaled that the pandemic-driven boom in demand for its bleaches, wipes and other surface cleaners was receding due to vaccinations

McDonald's sales surge amid reopening despite staffing "challenges"

(Reuters) -Global sales and profit for McDonald’s Corp surged past Wall Street targets on Wednesday as restaurants reopened despite staffing shortages and consumers lapped up a wildly popular celebrity meal inspired by South Korean pop band BTS.Slideshow ( 2 images )The fast-food chain also raised its guidance for fiscal 2021,

Reckitt reports disappointing second-quarter sales, says costs to hit margins

(Reuters) – Reckitt Benckiser Group posted disappointing second-quarter sales growth and warned on margins on Tuesday sending its shares 9% lower as costs rise and easing lockdowns slow growth in products such as Lysol disinfectants.FILE PHOTO: Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic, are seen in London,

J&J forecasts $2.5 billion in COVID-19 vaccine sales this year

(Reuters) – Johnson & Johnson on Wednesday forecast $2.5 billion in sales of its one-shot COVID-19 vaccine this year based on the current price of $5 per dose and said that could rise to $8 a dose by the end of the year.Slideshow ( 2 images )The company now expects

J&J raises revenue forecast, estimates $2.5 billion in COVID-19 vaccine sales

(Reuters) -Johnson & Johnson raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine this year, as it strives to quell production and safety problems and catch up with rivals Pfizer and Moderna.Slideshow ( 2 images )Although Johnson & Johnson’s single-dose

Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year

Slideshow ( 2 images )(Reuters) -Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns. J&J said it expects full-year sales of